Share on StockTwits

Masimo Corp. (NASDAQ:MASI)‘s stock had its “neutral” rating reaffirmed by investment analysts at Citigroup Inc. in a note issued to investors on Monday. They currently have a $27.00 price objective on the stock, down from their previous price objective of $29.00. Citigroup Inc.’s price target indicates a potential upside of 24.25% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. Analysts at BMO Capital Markets cut their price target on shares of Masimo Corp. from $26.00 to $24.00 in a research note on Friday. Separately, analysts at Roth Capital cut their price target on shares of Masimo Corp. from $32.00 to $28.00 in a research note on Friday. Finally, analysts at Piper Jaffray downgraded shares of Masimo Corp. from an “overweight” rating to a “neutral” rating in a research note on Friday. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Masimo Corp. presently has a consensus rating of “Hold” and a consensus target price of $27.40.

Shares of Masimo Corp. (NASDAQ:MASI) traded up 2.49% during mid-day trading on Monday, hitting $22.27. The stock had a trading volume of 398,391 shares. Masimo Corp. has a one year low of $19.30 and a one year high of $32.20. The stock has a 50-day moving average of $24.01 and a 200-day moving average of $25.79. The company has a market cap of $1.264 billion and a price-to-earnings ratio of 19.21.

Masimo Corp. (NASDAQ:MASI) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by $0.05. The company had revenue of $140.92 million for the quarter, compared to the consensus estimate of $145.76 million. During the same quarter in the previous year, the company posted $0.30 earnings per share. The company’s revenue for the quarter was up 2.5% on a year-over-year basis. Analysts expect that Masimo Corp. will post $1.24 EPS for the current fiscal year.

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.